BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26194602)

  • 1. Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.
    Bhat M; Ghali P; Rollet-Kurhajec KC; Bhat A; Wong P; Deschenes M; Sebastiani G
    Liver Transpl; 2015 Nov; 21(11):1383-94. PubMed ID: 26194602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients.
    Bhat M; Rollet-Kurhajec KC; Bhat A; Farag A; Deschenes M; Wong P; Ghali P; Sebastiani G
    Can J Gastroenterol Hepatol; 2017; 2017():4381864. PubMed ID: 28409147
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinase 1 and AST-to-Platelet Ratio Index as noninvasive biomarkers predict allograft fibrosis after pediatric liver transplantation.
    Beime J; Krech T; Hischke S; Grabhorn E; Brinkert F
    Clin Transplant; 2019 Oct; 33(10):e13676. PubMed ID: 31344272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative Year.
    Åberg F; Nordin A; Toivonen L; Isoniemi H
    Transplantation; 2016 Feb; 100(2):382-90. PubMed ID: 26683515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.
    Bhat M; Tazari M; Sebastiani G
    PLoS One; 2017; 12(9):e0185192. PubMed ID: 28953939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.
    Vergniol J; Boursier J; Coutzac C; Bertrais S; Foucher J; Angel C; Chermak F; Hubert IF; Merrouche W; Oberti F; de Lédinghen V; Calès P
    Hepatology; 2014 Jul; 60(1):65-76. PubMed ID: 24519328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
    PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
    Angulo P; Bugianesi E; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Barrera F; Haflidadottir S; Day CP; George J
    Gastroenterology; 2013 Oct; 145(4):782-9.e4. PubMed ID: 23860502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
    Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation.
    Chen PH; Limketkai BN; Trilianos P; Pirtini-Cetingul M; Woreta TA; Kim B; Gulsen MT; Segev DL; Cameron AM; Gurakar A
    Clin Transplant; 2016 May; 30(5):579-88. PubMed ID: 26913379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
    Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
    Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation.
    Bosch W; Heckman MG; Pungpapong S; Diehl NN; Shalev JA; Hellinger WC
    Transplantation; 2012 Apr; 93(7):723-8. PubMed ID: 22406819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-onset cytomegalovirus disease coded during hospital readmission in a multicenter, retrospective cohort of liver transplant recipients.
    Santos CA; Brennan DC; Chapman WC; Fraser VJ; Olsen MA
    Liver Transpl; 2015 May; 21(5):581-90. PubMed ID: 25678072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.
    Lai X; Chen G; Qiu J; Wang C; Chen L
    PLoS One; 2014; 9(11):e112938. PubMed ID: 25389964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.